STAAR Surgical Company (STAA) PE Ratio stood at $93.52: Odds are Looking Good After Recent Activity

QCOM

Witnessing the stock’s movement on the chart, on May 24, 2023, STAAR Surgical Company (NASDAQ: STAA) set off with pace as it heaved 2.31% to $60.32. During the day, the stock rose to $60.445 and sunk to $56.865 before settling in for the price of $58.96 at the close. Taking a more long-term approach, STAA posted a 52-week range of $46.35-$112.27.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 25.70%. Meanwhile, its Annual Earning per share during the time was 55.70%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 58.40%. This publicly-traded company’s shares outstanding now amounts to $48.25 million, simultaneously with a float of $47.89 million. The organization now has a market capitalization sitting at $2.94 billion. At the time of writing, stock’s 50-day Moving Average stood at $65.02, while the 200-day Moving Average is $69.40.

It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 882 employees. It has generated 295,011 per worker during the last fiscal year. Meanwhile, its income per employee was 40,202. The stock had 5.05 Receivables turnover and 0.75 Total Asset turnover. For the Profitability, stocks gross margin was +78.55, operating margin was +15.40 and Pretax Margin of +16.02.

STAAR Surgical Company (STAA) Ownership Facts and Figures

Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Instruments & Supplies industry. STAAR Surgical Company’s current insider ownership accounts for 0.10%, in contrast to 101.90% institutional ownership. According to the most recent insider trade that took place on Mar 17, this organization’s Chief Technology Officer sold 823 shares at the rate of 61.97, making the entire transaction reach 51,001 in total value, affecting insider ownership by 27,633. Preceding that transaction, on Dec 29, Company’s 10% Owner bought 39,090 for 47.93, making the whole transaction’s value amount to 1,873,431. This particular insider is now the holder of 8,783,082 in total.

STAAR Surgical Company (STAA) Earnings and Revenue Records

As on 3/30/2023, Multinational firm has announced its last quarter scores, in which it reported $0.05 earnings per share (EPS) for the period topping the consensus outlook (set at $0.02) by $0.03. This company achieved a net margin of +13.63 while generating a return on equity of 13.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.19 per share during the current fiscal year.

STAAR Surgical Company’s EPS increase for this current 12-month fiscal period is 58.40% and is forecasted to reach 1.11 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 30.00% through the next 5 years, which can be compared against the 55.70% growth it accomplished over the previous five years trading on the market.

STAAR Surgical Company (NASDAQ: STAA) Trading Performance Indicators

Let’s observe the current performance indicators for STAAR Surgical Company (STAA). It’s Quick Ratio in the last reported quarter now stands at 6.10. The Stock has managed to achieve an average true range (ATR) of 3.13. Alongside those numbers, its PE Ratio stands at $93.52, and its Beta score is 1.19. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 9.99. Similarly, its price to free cash flow for trailing twelve months is now 176.30.

In the same vein, STAA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.65, a figure that is expected to reach 0.18 in the next quarter, and analysts are predicting that it will be 1.11 at the market close of one year from today.

Technical Analysis of STAAR Surgical Company (STAA)

Going through the that latest performance of [STAAR Surgical Company, STAA]. Its last 5-days volume of 0.77 million indicated improvement to the volume of 0.68 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 38.87% While, its Average True Range was 3.31.

Raw Stochastic average of STAAR Surgical Company (STAA) in the period of the previous 100 days is set at 37.96%, which indicates a major rise in contrast to 31.76% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 51.96% that was lower than 55.79% volatility it exhibited in the past 100-days period.